Invention Grant
- Patent Title: Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
-
Application No.: US17161370Application Date: 2021-01-28
-
Publication No.: US11884748B2Publication Date: 2024-01-30
- Inventor: Ashok Bhandari , Gregory Thomas Bourne , Xiaoli Cheng , Brian Troy Frederick , Jie Zhang , Dinesh V. Patel , David Liu
- Applicant: Protagonist Therapeutics, Inc.
- Applicant Address: US CA Newark
- Assignee: Protagonist Therapeutics, Inc.
- Current Assignee: Protagonist Therapeutics, Inc.
- Current Assignee Address: US CA Newark
- Agency: Morrison & Foerster LLP
- The original application number of the division: US14800627 2015.07.15
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K7/02 ; C07K7/50 ; C07K7/64 ; C07K14/54 ; A61K38/00
Abstract:
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.
Public/Granted literature
- US20210363185A1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES Public/Granted day:2021-11-25
Information query
